Laboratory Corp. of America Holdings Company Profile (NYSE:LH)

About Laboratory Corp. of America Holdings

Laboratory Corp. of America Holdings logoLaboratory Corporation of America Holdings is a healthcare diagnostics company. The Company, together with its subsidiaries, is engaged in providing clinical laboratory services and drug development support. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD). The Company's LCD segment is an independent clinical laboratory business that consists of a network of approximately 40 primary laboratories and approximately 1,700 patient service centers (PSCs) along with a network of branches and STAT laboratories, which offer a menu of routine and frequently ordered tests. LCD offers a menu of over 4,700 tests, such as blood chemistry analyses, urinalyses, blood cell counts and thyroid tests. Its CDD segment offers drug development services, and provides a range of drug development solutions across the world, primarily to companies in the pharmaceutical and biotechnology industries.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: Health Care Services
  • Exchange: NYSE
  • Symbol: LH
  • CUSIP: 50540R40
Key Metrics:
  • Previous Close: $140.27
  • 50 Day Moving Average: $134.81
  • 200 Day Moving Average: $132.87
  • 52-Week Range: $108.95 - $143.14
  • Trailing P/E Ratio: 20.35
  • Foreward P/E Ratio: 13.77
  • P/E Growth: 1.61
  • Market Cap: $14.76B
  • Outstanding Shares: 103,300,000
  • Beta: 0.94
Profitability:
  • Net Margins: 6.85%
  • Return on Equity: 16.97%
  • Return on Assets: 6.20%
Debt:
  • Debt-to-Equity Ratio: 0.99%
  • Current Ratio: 1.39%
  • Quick Ratio: 1.28%
Additional Links:
Companies Related to Laboratory Corp. of America Holdings:

Analyst Ratings

Consensus Ratings for Laboratory Corp. of America Holdings (NYSE:LH) (?)
Ratings Breakdown: 4 Hold Ratings, 10 Buy Ratings
Consensus Rating:Buy (Score: 2.71)
Consensus Price Target: $152.00 (6.38% upside)

Analysts' Ratings History for Laboratory Corp. of America Holdings (NYSE:LH)
Show:
DateFirmActionRatingPrice TargetDetails
2/18/2017Barclays PLCSet Price TargetBuy$165.00View Rating Details
2/17/2017Jefferies Group LLCReiterated RatingHold$159.00View Rating Details
2/17/2017Canaccord GenuityBoost Price TargetBuy$140.00 -> $150.00View Rating Details
2/17/2017MizuhoBoost Price TargetNeutral$135.00 -> $139.00View Rating Details
2/6/2017Robert W. BairdDowngradeOutperform -> Neutral$138.00View Rating Details
1/18/2017Deutsche Bank AGReiterated RatingBuy$170.00View Rating Details
10/25/2016GabelliInitiated CoverageBuy$180.00View Rating Details
9/9/2016Citigroup Inc.Initiated CoverageNeutral$156.00View Rating Details
8/16/2016KeyCorpBoost Price TargetOverweight$143.00 -> $150.00View Rating Details
7/28/2016SunTrust Banks, Inc.Reiterated RatingBuyView Rating Details
7/27/2016Evercore ISIBoost Price TargetBuy$147.00 -> $155.00View Rating Details
6/9/2016Credit Suisse GroupReiterated RatingOutperform$135.00 -> $143.00View Rating Details
5/2/2016Morgan StanleyReiterated RatingBuyView Rating Details
3/23/2016Goldman Sachs Group, Inc. (The)Boost Price Target$119.00View Rating Details
3/4/2016William BlairReiterated RatingOutperformView Rating Details
2/19/2016Royal Bank of CanadaLower Price TargetSector Perform$135.00 -> $130.00View Rating Details
2/4/2016Raymond James Financial, Inc.Lower Price TargetOutperform$145.00 -> $135.00View Rating Details
12/17/2015Stifel NicolausDowngradeBuy -> HoldView Rating Details
4/28/2015J P Morgan Chase & CoBoost Price TargetOverweight$141.00 -> $144.00View Rating Details
3/27/2015JMP SecuritiesInitiated CoverageOutperform$165.00View Rating Details
3/24/2015Maxim GroupBoost Price TargetBuy$141.00 -> $160.00View Rating Details
3/23/2015Cantor FitzgeraldSet Price TargetBuy$115.00View Rating Details
(Data available from 2/25/2015 forward)

Earnings

Earnings History for Laboratory Corp. of America Holdings (NYSE:LH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/24/2017        
2/16/2017Q416$2.13$2.15$2.35 billion$2.39 billionViewListenView Earnings Details
10/26/2016Q316$2.29$2.25$2.38 billion$2.40 billionViewListenView Earnings Details
7/27/2016Q216$2.30$2.31$2.33 billion$2.40 billionViewListenView Earnings Details
4/25/2016Q116$1.96$2.02$2.19 billion$2.30 billionViewListenView Earnings Details
2/18/2016Q415$1.99$1.98$2.22 billion$2.24 billionViewListenView Earnings Details
10/26/2015Q315$2.07$2.07$2.25 billion$2.30 billionViewListenView Earnings Details
7/28/2015Q215$2.03$2.09$2.22 billion$2.20 billionViewListenView Earnings Details
4/27/2015Q115$1.63$1.73$1.79 billion$1.80 billionViewListenView Earnings Details
2/20/2015Q4$1.63$1.65$1.51 billionViewListenView Earnings Details
10/28/2014Q3$1.75$1.80$1.56 billion$1.55 billionViewListenView Earnings Details
7/18/2014Q214$1.77$1.84$1.50 billion$1.52 billionViewN/AView Earnings Details
4/28/2014Q114$1.58$1.51$1.45 billion$1.43 billionViewListenView Earnings Details
2/7/2014Q413$1.66$1.61$1.46 billion$1.44 billionViewListenView Earnings Details
10/18/2013Q313$1.80$1.80$1.45 billion$1.46 billionViewListenView Earnings Details
7/19/2013Q2 2013$1.80$1.80$1.46 billion$1.47 billionViewListenView Earnings Details
4/19/2013Q1 2013$1.77$1.74$1.45 billion$1.44 billionViewListenView Earnings Details
2/8/2013Q4 2012$1.62$1.54$1.39 billion$1.41 billionViewListenView Earnings Details
10/18/2012$1.74$1.76ViewN/AView Earnings Details
7/19/2012$1.76$1.77ViewN/AView Earnings Details
4/19/2012$1.67$1.74ViewN/AView Earnings Details
2/10/2012$1.41$1.46ViewN/AView Earnings Details
10/20/2011$1.50$1.61ViewN/AView Earnings Details
7/21/2011$1.53$1.64ViewN/AView Earnings Details
4/21/2011$1.46$1.52ViewN/AView Earnings Details
2/10/2011$1.31$1.34ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Laboratory Corp. of America Holdings (NYSE:LH)
Current Year EPS Consensus Estimate: $9.60 EPS
Next Year EPS Consensus Estimate: $10.38 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20169$1.95$2.05$1.98
Q2 20165$2.28$2.39$2.31
Q3 20165$2.28$2.36$2.31
Q4 20166$2.08$2.25$2.18
Q1 20174$2.16$2.33$2.23
Q2 20174$2.52$2.56$2.53
Q3 20174$2.42$2.51$2.46
Q4 20174$2.37$2.41$2.39
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Laboratory Corp. of America Holdings (NYSE:LH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Laboratory Corp. of America Holdings (NYSE:LH)
Insider Ownership Percentage: 1.14%
Institutional Ownership Percentage: 91.59%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/9/2016Lisa J UthgenanntInsiderSell1,177$140.00$164,780.00View SEC Filing  
8/4/2016Glenn A EisenbergCFOSell8,000$140.10$1,120,800.00View SEC Filing  
8/4/2016Robert E Mittelstaedt JrDirectorSell992$140.15$139,028.80View SEC Filing  
6/13/2016David P KingCEOSell196,400$128.00$25,139,200.00View SEC Filing  
4/27/2016Edward T DodsonInsiderSell9,392$126.42$1,187,336.64View SEC Filing  
3/31/2016F Samuel Eberts IIIInsiderSell4,219$116.85$492,990.15View SEC Filing  
3/31/2016James T Jr. BoyleCEOSell18,132$116.81$2,117,998.92View SEC Filing  
3/14/2016F Samuel Eberts IIIInsiderSell309$115.32$35,633.88View SEC Filing  
3/14/2016James T Jr. BoyleCEOSell1,543$115.32$177,938.76View SEC Filing  
2/25/2016Jean-Luc BelingardDirectorSell1,296$109.74$142,223.04View SEC Filing  
2/16/2016F Samuel Eberts IIIInsiderSell370$103.02$38,117.40View SEC Filing  
2/16/2016James T. Jr. BoyleCEOSell4,055$103.02$417,746.10View SEC Filing  
2/12/2016F Samuel Eberts IIIinsiderSell405$101.67$41,176.35View SEC Filing  
2/12/2016James T. Jr. BoyleCEOSell2,712$101.67$275,729.04View SEC Filing  
1/8/2016F Samuel Eberts IIIInsiderSell1,215$119.05$144,645.75View SEC Filing  
12/8/2015F Samuel Eberts IIIInsiderSell1,010$123.31$124,543.10View SEC Filing  
11/2/2015R Sanders WilliamsDirectorSell1,850$124.30$229,955.00View SEC Filing  
7/1/2015David P KingCEOSell50,000$121.78$6,089,000.00View SEC Filing  
4/29/2015Jean-Luc BelingardDirectorSell1,542$123.10$189,820.20View SEC Filing  
4/23/2015James T Jr. BoyleCEOSell1,394$126.56$176,424.64View SEC Filing  
3/31/2015Mark E BrecherCMOSell20,625$126.98$2,618,962.50View SEC Filing  
3/30/2015Mark E BrecherCMOSell20,278$126.98$2,574,900.44View SEC Filing  
3/3/2015James T Jr. BoyleCOOSell1,237$123.70$153,016.90View SEC Filing  
2/13/2015James T Jr. BoyleCOOSell6,597$116.68$769,737.96View SEC Filing  
9/22/2014David P KingCEOSell65,234$104.71$6,830,652.14View SEC Filing  
9/5/2014R Sanders WilliamsDirectorSell2,000$107.95$215,900.00View SEC Filing  
8/22/2014David P KingCEOSell65,233$106.10$6,921,221.30View SEC Filing  
7/22/2014David P KingCEOSell65,233$105.55$6,885,343.15View SEC Filing  
6/9/2014James T Jr. BoyleCOOSell38,600$103.00$3,975,800.00View SEC Filing  
5/7/2014M Keith WeikelDirectorSell1,984$98.28$194,987.52View SEC Filing  
3/28/2014James Jr. BoyleCOOSell2,521$98.36$247,965.56View SEC Filing  
3/7/2014William HayesCFOSell23,848$94.40$2,251,251.20View SEC Filing  
2/13/2014James Jr. BoyleCOOSell4,123$90.29$372,265.67View SEC Filing  
2/11/2014James Jr. BoyleCOOSell1,204$91.15$109,744.60View SEC Filing  
1/27/2014David KingCEOSell24,200$90.15$2,181,630.00View SEC Filing  
12/24/2013David KingCEOSell25,000$90.79$2,269,750.00View SEC Filing  
10/24/2013David P KingCEOSell25,000$100.91$2,522,750.00View SEC Filing  
10/17/2013James T Jr. BoyleCOOSell24,400$102.00$2,488,800.00View SEC Filing  
9/25/2013David KingCEOSell25,000$99.06$2,476,500.00View SEC Filing  
8/26/2013David KingCEOSell25,000$96.60$2,415,000.00View SEC Filing  
8/21/2013Robert Mittelstaedt, Jr.DirectorSell7,429$96.86$719,572.94View SEC Filing  
7/24/2013David P KingCEOSell25,000$97.72$2,443,000.00View SEC Filing  
6/24/2013David P KingCEOSell25,000$98.66$2,466,500.00View SEC Filing  
6/7/2013James T Jr. BoyleCOOSell63,100$99.63$6,286,653.00View SEC Filing  
5/28/2013Mark E BrecherInsiderSell16,900$100.92$1,705,548.00View SEC Filing  
5/21/2013William B HayesCFOSell127,200$100.00$12,720,000.00View SEC Filing  
5/17/2013F Samuel Eberts IIIInsiderSell10,000$98.47$984,700.00View SEC Filing  
5/10/2013James T Jr. BoyleCOOSell68,908$93.82$6,464,948.56View SEC Filing  
5/8/2013Jean-Luc BelingardDirectorSell2,536$92.88$235,543.68View SEC Filing  
4/11/2013William B HayesCFOSell22,234$95.00$2,112,230.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Laboratory Corp. of America Holdings (NYSE:LH)
DateHeadline
streetinsider.com logoLab Corp. (LH) to Acquire Pathology Associates Medical Laboratories - StreetInsider.com (NYSE:LH)
www.streetinsider.com - February 25 at 8:23 AM
realistinvestor.com logoLaboratory Corporation of America Holdings (NYSE:LH) Deferred Tax Assets At $37.2 Millions (NYSE:LH)
www.realistinvestor.com - February 24 at 7:31 PM
bizjournals.com logoMedford's Seventh Sense wins narrow FDA approval for blood-collection device (NYSE:LH)
www.bizjournals.com - February 23 at 6:15 PM
finance.yahoo.com logoLabCorp to Acquire Pathology Associates Medical Laboratories from Providence Health & Services and Catholic Health Initiatives (NYSE:LH)
finance.yahoo.com - February 23 at 6:15 PM
finance.yahoo.com logo4:33 pm Laboratory Corp to acquire all of the ownership interest in Pathology Associates Medical Laboratories and also Providence Health & Services' interest in some JVs; terms not disclosed (NYSE:LH)
finance.yahoo.com - February 23 at 6:15 PM
biz.yahoo.com logoLABORATORY CORP OF AMERICA HOLDINGS Files SEC form 8-K, Regulation FD Disclosure (NYSE:LH)
biz.yahoo.com - February 23 at 6:15 PM
bizjournals.com logoLabCorp to buy 1,600-employee Washington firm (NYSE:LH)
www.bizjournals.com - February 23 at 6:15 PM
News IconMedical Laboratories & Research: Laboratory Corporation of America Holdings (NYSE:LH) Position of the day (NYSE:LH)
twincountynews.com - February 22 at 12:18 PM
capitalcube.com logoLaboratory Corp. of America Holdings :LH-US: Earnings Analysis: 2016 By the Numbers : February 21, 2017 (NYSE:LH)
www.capitalcube.com - February 22 at 12:18 PM
News IconLaboratory Corporation of America Holdings (LH) Stake Maintained by Fifth Third Bancorp (NYSE:LH)
nyhetsbanken.info - February 19 at 10:05 AM
News IconLaboratory Corporation of America Holdings (LH) Announces Quarterly Earnings Results (NYSE:LH)
naijaoversabi.com - February 19 at 10:05 AM
marketexclusive.com logoAnalyst Activity – Mizuho Raises Its Price Target On Laboratory Corporation of America Holdings (NYSE:LH) to $139.00 (NYSE:LH)
marketexclusive.com - February 18 at 12:02 PM
News IconImpact of Brokerage Rating on Laboratory Corporation of America Holdings(LH) (NYSE:LH)
cloudhostinghq.net - February 18 at 12:02 PM
News IconInvestors Catching Stocks: Laboratory Corp. of America Holdings (NYSE:LH) (NYSE:LH)
oakridgeobserver.com - February 18 at 12:02 PM
News IconLaboratory Corporation Of America Holdings (NYSE:LH) Valuation According To Analysts (NYSE:LH)
xboxonezone.com - February 18 at 12:02 PM
News IconMizuho Raises Laboratory Corporation of America Holdings (LH) Price Target to $139.00 (NYSE:LH)
techknowbits.com - February 18 at 12:02 PM
News IconWhy Investors remained confident on Laboratory Corporation of America Holdings (LH), The Clorox Company (CLX)? - StockNewsJournal (NYSE:LH)
stocknewsjournal.com - February 17 at 4:27 PM
capitalcube.com logoLaboratory Corp. of America Holdings :LH-US: Earnings Analysis: Q4, 2016 By the Numbers : February 17, 2017 (NYSE:LH)
www.capitalcube.com - February 17 at 4:27 PM
finance.yahoo.com logoLabCorp (LH) Beats on Q4 Earnings & Revenue Estimates - Yahoo Finance (NYSE:LH)
finance.yahoo.com - February 17 at 9:26 AM
4-traders.com logoLaboratory of America : LabCorp tops Street 4Q forecasts (NYSE:LH)
www.4-traders.com - February 16 at 10:00 PM
rttnews.com logoEARNINGS SUMMARY: Details of Laboratory Corporation Of America Holdings Q4 Earnings Report (NYSE:LH)
www.rttnews.com - February 16 at 10:00 PM
biz.yahoo.com logoQ4 2016 Laboratory Corporation of America Holdings Earnings Release - Before Market Open (NYSE:LH)
us.rd.yahoo.com - February 16 at 10:00 PM
us.rd.yahoo.com logoLabCorp (LH) Beats on Q4 Earnings & Revenue Estimates (NYSE:LH)
us.rd.yahoo.com - February 16 at 10:00 PM
biz.yahoo.com logoLaboratory Corporation of America Holdings Earnings Call scheduled for 9:00 am ET today (NYSE:LH)
us.rd.yahoo.com - February 16 at 10:00 PM
finance.yahoo.com logoEdited Transcript of LH earnings conference call or presentation 16-Feb-17 2:00pm GMT (NYSE:LH)
finance.yahoo.com - February 16 at 10:00 PM
seekingalpha.com logoLaboratory of America Holdings (LH) Q4 2016 Results - Earnings Call Transcript - Seeking Alpha (NYSE:LH)
seekingalpha.com - February 16 at 4:59 PM
investopedia.com logoLaboratory Corporation 4Q Net Beats Street (LH) - Investopedia (NYSE:LH)
www.investopedia.com - February 16 at 4:59 PM
investopedia.com logoLaboratory Corporation 4Q Earnings Beats Street (NYSE:LH)
www.investopedia.com - February 16 at 4:59 PM
thestreet.com logoAmid M&A Buzz, LabCorp CEO Says Deal Pipeline 'Very Healthy' (NYSE:LH)
www.thestreet.com - February 16 at 4:59 PM
finance.yahoo.com logoLaboratory Corporation of America® Holdings Announces Record 2016 Fourth Quarter and Full Year Results and ... - Yahoo Finance (NYSE:LH)
finance.yahoo.com - February 16 at 8:00 AM
finance.yahoo.com logoLabCorp tops Street 4Q forecasts - Yahoo Finance (NYSE:LH)
finance.yahoo.com - February 16 at 8:00 AM
News IconLaboratory Corp. of America Holdings (LH) Releases Earnings Results, Reports EPS of $2.15 EPS - Highland Mirror (NYSE:LH)
www.highlandmirror.com - February 16 at 8:00 AM
sg.finance.yahoo.com logoLabCorp tops Street 4Q forecasts (NYSE:LH)
sg.finance.yahoo.com - February 16 at 8:00 AM
bizjournals.com logoLabCorp to acquire Washington company, per report (NYSE:LH)
www.bizjournals.com - February 16 at 8:00 AM
finance.yahoo.com logoMedTech Stocks' Q4 Earnings on Feb 16: LH, WST and MDRX (NYSE:LH)
finance.yahoo.com - February 15 at 9:23 PM
nasdaq.com logoLabCorp (LH) Q4 Earnings: What's in the Cards for the Stock? - Nasdaq (NYSE:LH)
www.nasdaq.com - February 14 at 7:45 PM
finance.yahoo.com logoLabCorp (LH) Q4 Earnings: What's in the Cards for the Stock? (NYSE:LH)
finance.yahoo.com - February 14 at 7:45 PM
News IconLeading stocks in today’s market: Laboratory Corporation of America Holdings (NYSE:LH) (NYSE:LH)
twincountynews.com - February 11 at 12:05 AM
capitalcube.com logoLaboratory Corp. of America Holdings breached its 50 day moving average in a Bullish Manner : LH-US : February 8, 2017 (NYSE:LH)
www.capitalcube.com - February 8 at 7:02 PM
News IconBest stocks of the day: Laboratory Corporation of America Holdings (NYSE:LH) (NYSE:LH)
hoyentv.com - February 7 at 7:36 PM
bloomberg.com logoLabcorp: Not That Deal, Please (NYSE:LH)
us.rd.yahoo.com - February 7 at 7:36 PM
investopedia.com logoLabCorp Mulls Buying Clinical Trials Firm PPD (LH) (NYSE:LH)
www.investopedia.com - February 6 at 6:24 PM
us.rd.yahoo.com logoLabCorp In Talks to Buy Contract Researcher PPD (NYSE:LH)
us.rd.yahoo.com - February 6 at 6:24 PM
us.rd.yahoo.com logo3 Reasons Baird Downgraded Laboratory Corp Of America (NYSE:LH)
us.rd.yahoo.com - February 6 at 6:24 PM
bizjournals.com logoLabCorp seeks to acquire N.C. clinical trials firm PPD, per report (NYSE:LH)
us.rd.yahoo.com - February 6 at 6:24 PM
us.rd.yahoo.com logoThe Biggest Loser: Laboratory Corp Tumbles 5.7% (NYSE:LH)
us.rd.yahoo.com - February 6 at 6:24 PM
us.rd.yahoo.com logoLaboratory Corp downgraded by Robert W. Baird (NYSE:LH)
us.rd.yahoo.com - February 6 at 10:11 AM
nasdaq.com logoEXCLUSIVE-LabCorp explores acquisition of clinical trials firm PPD -sources (NYSE:LH)
www.nasdaq.com - February 3 at 6:57 PM
News IconLaboratory Corp Amer Hldgs (LH) Holder Seatown Holdings Has Decreased Position by $12.13 Million (NYSE:LH)
randolphguide.com - January 30 at 6:58 PM
News IconStock in Focus: Laboratory Corporation of America Holdings (NYSE:LH) - Gilbert Daily (NYSE:LH)
gilbertdaily.com - January 29 at 4:27 AM

Social

What is Laboratory Corp. of America Holdings' stock symbol?

Laboratory Corp. of America Holdings trades on the New York Stock Exchange (NYSE) under the ticker symbol "LH."

Where is Laboratory Corp. of America Holdings' stock going? Where will Laboratory Corp. of America Holdings' stock price be in 2017?

14 equities research analysts have issued 1-year price objectives for Laboratory Corp. of America Holdings' stock. Their forecasts range from $119.00 to $180.00. On average, they anticipate Laboratory Corp. of America Holdings' share price to reach $152.00 in the next year.

When will Laboratory Corp. of America Holdings announce their earnings?

Laboratory Corp. of America Holdings is scheduled to release their next quarterly earnings announcement on Monday, April, 24th 2017.

What are analysts saying about Laboratory Corp. of America Holdings stock?

Here are some recent quotes from research analysts about Laboratory Corp. of America Holdings stock:

  • Canaccord Genuity analysts commented, "LH bounced back from an underwhelming Q3 with a good Q4 that beat our/consensus estimates on the top and bottom lines. The 2017 guide is what we expected and we believe sets an appropriate bar for the company to execute against. LH spent a good portion of time on its call (in the Q&A) defending its strategic planning and responded to questions about its reported interest (Reuters) to acquire NC-based CRO Pharmaceutical Product Development (PPD) for ~$8 billion. While on one hand the deal would make sense to bolster its Covance business, our sense from investors is that most would prefer to see LH return more of its capital to shareholders in the form of share repurchases, which LH re-initiated in Q4. Regardless, we think the stock is cheap and it remains one of our five top picks for 2017 as we expect "mean-reverted" multiple expansion and another solid year of FCF (~$975M, or $9.43/sh.) and strong capital deployment. BUY. We raise our estimates and PT to $150 from $140." (2/17/2017)
  • Mizuho analysts commented, "We are raising our price target to $139 ($135 previously) post 4Q on betterthan-expected cash flow guidance. We are maintaining our 2017E and 2018E adjusted EPS estimates of $9.65 and $10.32, respectively. LH reported a good 4Q and initial 2017 guidance despite some noise. The company also noted a more conservative approach to its CRO metrics, which we view favorably." (2/17/2017)
  • According to Zacks Investment Research, "Ahead of its fourth quarter report, in majority of the last three months, LabCorp’s share price persistently traded below the Zacks categorised Medical Dental Supplies industry trend. In fact, the underperformance took place particularly when the company's third-quarter’s earnings lagged the Zacks Consensus Estimate with in line revenues. Intense competition from several commercial laboratories and hospitals is a major headwind. Unfavorable foreign exchange continues to remain as a major dampener to the company’s overall results. Last quarter was poor with respect to organic volume growth in LabCorp Diagnostics. On a positive note, revenue growth was noted in Covance Drug Development. We believe the recently completed buyout of Sequenom will boost LabCorp's women's health test menu. LabCorp continues to gain from organic growth by introducing new tests to existing and new customers in the near term." (2/8/2017)

Who owns Laboratory Corp. of America Holdings stock?

Laboratory Corp. of America Holdings' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include State Street Corp (4.40%), Glenview Capital Management LLC (4.07%), FMR LLC (1.83%), Iridian Asset Management LLC CT (1.63%), Institutional Capital LLC (1.52%) and Dimensional Fund Advisors LP (1.10%). Company insiders that own Laboratory Corp. of America Holdings stock include David P King, Edward T Dodson, F Samuel Eberts III, Glenn A Eisenberg, James T Jr Boyle, Jean-Luc Belingard, Lisa J Uthgenannt, Mark E Brecher, R Sanders Williams and Robert E Mittelstaedt Jr.

Who sold Laboratory Corp. of America Holdings stock? Who is selling Laboratory Corp. of America Holdings stock?

Laboratory Corp. of America Holdings' stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Allianz Asset Management AG, Chieftain Capital Management Inc., Baird Financial Group Inc., Roystone Capital Management LP, Nicholas Co. Inc. WI, Renaissance Technologies LLC and ING Groep NV. Company insiders that have sold Laboratory Corp. of America Holdings stock in the last year include David P King, Edward T Dodson, F Samuel Eberts III, Glenn A Eisenberg, James T Jr Boyle, Jean-Luc Belingard, Lisa J Uthgenannt and Robert E Mittelstaedt Jr.

Who bought Laboratory Corp. of America Holdings stock? Who is buying Laboratory Corp. of America Holdings stock?

Laboratory Corp. of America Holdings' stock was purchased by a variety of institutional investors in the last quarter, including Glenview Capital Management LLC, Iridian Asset Management LLC CT, Alyeska Investment Group L.P., Janus Capital Management LLC, Asset Management One Co. Ltd., Thompson Siegel & Walmsley LLC, Champlain Investment Partners LLC and Federated Investors Inc. PA.

How do I buy Laboratory Corp. of America Holdings stock?

Shares of Laboratory Corp. of America Holdings can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Laboratory Corp. of America Holdings stock cost?

One share of Laboratory Corp. of America Holdings stock can currently be purchased for approximately $142.89.

Laboratory Corp. of America Holdings (NYSE:LH) Chart for Saturday, February, 25, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Laboratory Corp. of America Holdings (NYSE:LH)

Earnings History Chart

Earnings by Quarter for Laboratory Corp. of America Holdings (NYSE:LH)

Dividend History Chart

Dividend Payments by Quarter for Laboratory Corp. of America Holdings (NYSE:LH)

Last Updated on 2/25/2017 by MarketBeat.com Staff